KONDRONOVA Capsules, # 30
Scope of the drug
Musculoskeletal system
Release form
Capsules
Manufacturer country
India
Package quantity, pcs
thirty
Scope of application
Rheumatology
Kondronova caps.
No. 30
Name ENG
KONDROnova
Clinical and pharmacological group
A drug that regulates metabolism in cartilage tissue
ATX code
Other drugs for the treatment of diseases of the musculoskeletal system
Dosage
250mg + 200mg
Structure
1 caps .: chondroitin sulfate 200 mg, glucosamine hydrochloride 250 mg
Indications
Osteoarthritis of the peripheral joints and joints of the spine.
Storage conditions and periods
In a dry, dark place, at a temperature not exceeding 30 degrees.
Expiration date: 2 years
INN / Active ingredient
Chondroitin sulfate + glucosamine
Contraindications
Hypersensitivity to drug components.
Pregnancy and lactation.
Childhood.
Carefully:
Diabetes.
Bronchial asthma.
Bleeding tendency.
Thrombophlebitis.
Specifications
Scope of the drug
Musculoskeletal system
Release form
Capsules
Manufacturer country
India
Package quantity, pcs
thirty
Scope of application
Rheumatology
Minimum age from
18 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Panacea Biotec
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Tissue repair stimulant
Dosage form
Capsules
Packaging
Box
Expiration date in days
730
The target audience
Adult
Dosage (volume) of the substance in the preparation
chondroitin sulfate 200 mg
glucosamine hydrochloride 250 mg
Package weight, g
35
Category
:
Joints
,
Treatment of diseases of the musculoskeletal system
,
Synovial fluid
,
Bone metabolism
Mode of application
:
Orally.
Adults take 2 capsules 2-3 times a day.
After 60 days of therapy, the dose should be gradually reduced depending on the needs of the individual patient.
Course of treatment: 2-3 months (the duration of treatment is determined by the doctor).
A second course of treatment is possible only after consulting a doctor.
Anatomical and therapeutic characteristics
:
M09AX Other drugs for the treatment of diseases of the musculoskeletal system